Look for:

Our offer for

REGENERON PHARMACEUTICALS INC.


ISIN:
US75886F1075
WKN:
75886F107

2023/02/02 22:00:00
Price
751.20 USD
Difference -0.90% (-6.80)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)73,768 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)754.00 USD (200)
Ask (Ask size)776.00 USD (100)
Open749.20 USD
High758.72 USD
Low741.45 USD
Close (prev. day)758.00 USD
VWAP750.687912 USD
Volume (pcs)935,180
Trading volume701,966,889.46
Number of trades30,271
Last size85,753

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/02/02 22:00:00
Price
751.20 USD
Difference -0.90% (-6.80)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)73,768 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)754.00 USD (200)
Ask (Ask size)776.00 USD (100)
Open749.20 USD
High758.72 USD
Low741.45 USD
Close (prev. day)758.00 USD
VWAP750.687912 USD
Volume (pcs)935,180
Trading volume701,966,889.46
Number of trades30,271
Last size85,753

Performance and Risk

6m1Y3Y
Perf (%)+30.65%+20.61%+122.29%
Perf (abs.)+176.24+128.35+413.26
Beta0.660.590.57
Volatility38.1433.6135.01
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)749.39 USD (693,769)
Ø price 30 days | Ø volume 30 days (pcs.)726.97 USD (593,607)
Ø price 100 days | Ø volume 100 days (pcs.)729.80 USD (691,149)
Ø price 250 days | Ø volume 250 days (pcs.)672.63 USD (684,364)
YTD High | date762.10 USD (2023/02/01)
YTD Low | date668.00 USD (2023/01/09)
52 Weeks High | date779.00 USD (2022/12/08)
52 Weeks Low | date538.01 USD (2022/06/14)

All listings for REGENERON PHARMACEUTICALS INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/02/0217:35691.40 EUR0.002
Vienna Stock Exchange2023/02/0117:32693.30 EUR0.002
Tradegate2023/02/0222:26687.90 EUR0.1123
Stuttgart2023/02/0221:19687.40 EUR0.018
Nasdaq2023/02/0222:00751.20 USD701.9730,271
Munich2023/02/0208:01690.70 EUR0.001
London Stock Exchange2023/01/2718:04745.61 USD1.181
Hanover2023/02/0208:01690.20 EUR0.001
Hamburg2023/02/0208:01690.20 EUR0.001
Frankfurt2023/02/0215:19679.90 EUR0.065
Duesseldorf2023/02/0221:00684.10 EUR0.0011
Berlin2023/02/0208:01689.50 EUR0.001
BX Swiss---0.00-

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=99472&ID_TYPE_IMAGE_LOGO=2

Contact Details

REGENERON PHARMACEUTICALS INC.
- -
777 Old Saw Mill River Road - 10591-6707 Tarrytown
Telefon: 1-914-847-7000
Fax: -
E-mail: -

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Members of Management Board

P. VagelosChairman of Board of Directors
Bonnie BasslerMember of Board of Directors
Craig ThompsonMember of Board of Directors
George YancopoulosMember of Board of Directors
Huda ZoghbiMember of Board of Directors
Joseph GoldsteinMember of Board of Directors
Marc Tessier-LavigneMember of Board of Directors
Michael BrownMember of Board of Directors
N. ColesMember of Board of Directors
Arthur RyanMember of Board of Directors
Christine PoonMember of Board of Directors
George SingMember of Board of Directors
Leonard SchleiferChairman of Managing Board
Alan ShuldinerMember of Executive Committee
Andrew MurphyMember of Executive Committee
David WeinreichMember of Executive Committee
Kerry ReinertsenMember of Executive Committee
Ned BraunsteinMember of Executive Committee
Neil StahlMember of Executive Committee
Beth HollyMember of Executive Committee
Bob McCowanMember of Executive Committee
Christopher FenimoreMember of Executive Committee
Daniel van PlewMember of Executive Committee
Gerald UnderwoodMember of Executive Committee
Joseph LaRosaMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer